Author

John Porter

Observed name: Porter J

Institution: Chapter Arts Centre

Observed institution: Chapter Arts Centre

ORCID: 0000-0002-1601-500X

Observed ORCID: 0000-0002-1601-500X

OpenAlex ID: A5124824910

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Rodica Pop-Busui, Søren Rasmussen, et al. · JAMA Internal Medicine · 18

Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren

2026 · Alessandro Prete, Verena Theiler-Schwetz, et al. · EClinicalMedicine · 11

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Sharon L. Mulvagh, Silvio E. Inzucchi, et al. · JAMA Cardiology · 6

CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency

2024 · Alessandro Prete, Verena Theiler-Schwetz, et al. · Endocrine Abstracts · 1

First and Subsequent Major Cardiovascular Events With Oral Semaglutide in High-Risk Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

2026 · Nikolaus Marx, John E. Deanfield, et al. · JAMA Cardiology

Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren

2026 · Prete A, Theiler-Schwetz V, et al. · Yearbook of pediatric endocrinology

Switching patients with Congenital Adrenal Hyperplasia to modified-release Hydrocortisone capsules: Relative bioavailability and disease control

2026 · Ross RJM, Arlt W, et al. · Yearbook of pediatric endocrinology

RC9.5 - ECE_2071 - Replacing early morning cortisol reduces fatigue: post-hoc analysis of AddiQol in CHAMPAIN, a double-blind study comparing Chronocort and Plenadren

2026 · Irina Chifu, Alessandro Prete, et al. · European Journal of Endocrinology

Replacing the early morning cortisol rise reduces fatigue and improves qol in adrenal insufficiency: a double-blind study

2026 · Aled Rees, Alessandro Prete, et al. · Endocrine Abstracts

Corrigendum to “Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren”[eClinical Medicine 91(2026); 103714]

2026 · Alessandro Prete, Verena Theiler-Schwetz, et al. · EClinicalMedicine

Morning cortisol levels in patients with established primary adrenal insufficiency

2024 · Alessandro Prete, Verena Theiler-Schwetz, et al. · Endocrine Abstracts

Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA

2017 · Carsten Bonnemann, Marc Boutin, et al. · Newcastle University ePrints (Newcastle Univesity)

Works count: 12

Citation count: 36

H-index: 3

I10-index: 2